The Emergence of Comprehensive Genomic Profiling to Guide Precision Medicine Male breast cancer, despite its low incidence rate—estimated to account for less than 1% of all cases in the US—presents a unique set of clinical challenges. Because the disease is overwhelmingly hormone receptor-positive (ER+), the initial focus has traditionally been on endocrine therapy. However, the...